Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 6437208, 8 pages
http://dx.doi.org/10.1155/2016/6437208
Research Article

Growing Menace of Antibacterial Resistance in Clinical Isolates of Pseudomonas aeruginosa in Nepal: An Insight of Beta-Lactamase Production

1Department of Microbiology, Chitwan Medical College, Bharatpur, Chitwan, Nepal
2Department of Laboratory Medicine, Chitwan Medical College, Bharatpur, Chitwan, Nepal

Received 15 February 2016; Accepted 17 July 2016

Academic Editor: Wejdene Mansour

Copyright © 2016 Shamshul Ansari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. W. Wirth, S. U. Picoli, V. V. Cantarelli et al., “Metallo-β-lactamase-producing Pseudomonas aeruginosa in two hospitals from Southern Brazil,” Brazilian Journal of Infectious Diseases, vol. 13, no. 3, pp. 170–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M.-L. Lambert, C. Suetens, A. Savey et al., “Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study,” The Lancet Infectious Diseases, vol. 11, no. 1, pp. 30–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Manchanda and N. P. Singh, “Occurrence and detection of AmpC β-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India,” Journal of Antimicrobial Chemotherapy, vol. 51, no. 2, pp. 415–418, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Basak, R. O. Attal, and M. Rajurkar, “Pseudomonas aeruginosa and newer β-lactamases: an emerging resistance threat,” in Infection Control—Updates, 2012, C. Sudhakar, Ed., InTech, 2012, http://www.intechopen.com/books/infection-control-updates/pseudomonasaeruginosa-and-newer-lactamases-an-emerging-resistance-threat. View at Google Scholar
  5. X.-Z. Li, H. Nikaido, and K. Poole, “Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa,” Antimicrobial Agents and Chemotherapy, vol. 39, no. 9, pp. 1948–1953, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. G. A. Jacoby, “AmpC β-lactamases,” Clinical Microbiology Reviews, vol. 22, no. 1, pp. 161–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Black, E. S. Moland, and K. S. Thomson, “AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-lactamases,” Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3110–3113, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Singhal, T. Mathur, S. Khan et al., “Evaluation of methods for AmpC β-lactamase in gram negative clinical isolates from tertiary care hospitals,” Indian Journal of Medical Microbiology, vol. 23, no. 2, pp. 120–124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. H. D. Isenberg, Clinical Microbiology Procedures Handbook, ASM Press, Washington, DC, USA, 2nd edition, 2004.
  10. Clinical and Laboratory Standard Institute (CLSI), “Performance standards for antimicrobial susceptibility testing,” CLSI M100-S16, Clinical and Laboratory Standard Institute (CLSI), Wayne, Pa, USA, 2006. View at Google Scholar
  11. National Committee for Clinical Laboratory Standards (NCCLS), “Performance standards for antimicrobial susceptibility testing; eighth informational supplement,” NCCLS Document M100-S8, NCCLS, Wayne, Pa, USA, 1998. View at Google Scholar
  12. M. W. Carter, K. J. Oakton, M. Warner, and D. M. Livermore, “Detection of extended-spectrum β-lactamases in klebsiellae spp with the Oxoid combination disk method,” Journal of Clinical Microbiology, vol. 38, no. 11, pp. 4228–4232, 2000. View at Google Scholar · View at Scopus
  13. D. Yong, K. Lee, J. H. Yum, H. B. Shin, G. M. Rossolini, and Y. Chong, “Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp,” Journal of Clinical Microbiology, vol. 40, no. 10, pp. 3798–3801, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. P. F. Harrison and J. Lederberg, “Antibmicrobial resistance: issues and options: workshop report,” Tech. Rep., Institute of Medicine, National Academy Press, Washington, DC, USA, 1998. View at Google Scholar
  15. A. Hauser, “Pseudomonas aeruginosa,” Nature, http://www.nature.com/nrmicro/posters/pseudomonas/posters.pdf.
  16. S. Khan, P. Singh, A. Rashmi, and K. Khanal, “Recent trend of acquisition of multi-drug resistance in Pseudomonas aeruginosa,” Asian Pacific Journal of Microbiology Research, vol. 2, no. 1, pp. 1–5, 2014. View at Google Scholar
  17. U. Algun, A. Arisoy, T. Gunduz, and B. Ozbakkaloglu, “The resistance of Pseudomonas aeruginosa strains to fluoroquinolone group of antibiotics,” Indian Journal of Medical Microbiology, vol. 22, no. 2, pp. 112–114, 2004. View at Google Scholar · View at Scopus
  18. K. B. Holten and E. M. Onusko, “Appropriate prescribing of oral beta-lactam antibiotics,” American Family Physician, vol. 62, no. 3, pp. 611–620, 2000. View at Google Scholar · View at Scopus
  19. S. K. Mishra, J. Acharya, H. P. Kattel, J. Koirala, B. P. Rijal, and B. M. Pokhrel, “Metallo-beta-lactamase producing gram-negative bacterial isolates,” Journal of Nepal Health Research Council, vol. 10, no. 22, pp. 208–213, 2012. View at Google Scholar · View at Scopus
  20. J. B. Sherchan, P. Gurung, D. S. Bam, and J. B. Sherchand, “Multi-drug resistant bacterial strains in lower respiratory tract infections, antibiotic sensitivity patterns and risk factors,” Nepal Journal of Science and Technology, vol. 13, no. 1, pp. 157–163, 2012. View at Publisher · View at Google Scholar
  21. R. Rafiee, F. Eftekhar, S. A. Tabatabaei, and D. M. Tehrani, “Prevalence of extended-spectrum and metallo β-lactamase production in AmpC β-lactamase producing Pseudomonas aeruginosa isolates from burns,” Jundishapur Journal of Microbiology, vol. 7, no. 9, Article ID e16436, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Behera, P. Mathur, A. Das, A. Kapil, and V. Sharma, “An evaluation of four different phenotypic techniques for detection of metallo-β-lactamase producing Pseudomonas aeruginosa,” Indian Journal of Medical Microbiology, vol. 26, no. 3, pp. 233–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. P. R. Shankar, P. Partha, A. K. Dubey, P. Mishra, and V. Y. Deshpande, “Intensive care unit drug utilization in a teaching hospital in Nepal,” Kathmandu University Medical Journal, vol. 3, no. 10, pp. 130–137, 2005. View at Google Scholar · View at Scopus
  24. C. P. Bhatt and M. Lakhey, “The distribution of pathogens causing wound infection and their antibiotic susceptibility pattern,” Journal of Nepal Health Research Council, vol. 5, no. 1, pp. 22–26, 2006. View at Google Scholar
  25. P. Baral, S. Neupane, B. P. Marasini, K. R. Ghimire, B. Lekhak, and B. Shrestha, “High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal,” BMC Research Notes, vol. 5, article 38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Chander and M. S. Raza, “Antimicrobial susceptibility patterns of Pseudomonas aeruginosa clinical isolates at a tertiary care hospital in Kathmandu, Nepal,” Asian Journal of Pharmaceutical and Clinical Research, vol. 6, no. 3, pp. 235–238, 2013. View at Google Scholar · View at Scopus
  27. G. Agrawal, R. Lodhi, U. Kamalakar, R. Khadse, and S. Jalgaonkar, “Study of metallo-β-lactamase production in clinical isolates of Pseudomonas aeruginosa,” Indian Journal of Medical Microbiology, vol. 26, no. 4, pp. 349–351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Khanal, D. R. Joshi, D. R. Bhatta, U. Devkota, and B. M. Pokhrel, “β-Lactamase-producing multidrug-resistant bacterial pathogens from tracheal aspirates of intensive care unit patients at national institute of neurological and allied sciences, Nepal,” ISRN Microbiology, vol. 2013, Article ID 847569, 5 pages, 2013. View at Publisher · View at Google Scholar
  29. P. S. Stewart and J. W. Costerton, “Antibiotic resistance of bacteria in biofilms,” The Lancet, vol. 358, no. 9276, pp. 135–138, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. D. M. Livermore, “Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?” Clinical Infectious Diseases, vol. 34, no. 5, pp. 634–640, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Bush, G. A. Jacoby, and A. A. Medeiros, “A functional classification scheme for β-lactamases and its correlation with molecular structure,” Antimicrobial Agents and Chemotherapy, vol. 39, no. 6, pp. 1211–1233, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. W.-H. Zhao and Z.-Q. Hu, “β-Lactamases identified in clinical isolates of Pseudomonas aeruginosa,” Critical Reviews in Microbiology, vol. 36, no. 3, pp. 245–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Shrestha, R. Chaudhari, S. Karmacharya et al., “Prevalence of nosocomial lower respiratory tract infections caused by multi-drug resistance pathologens,” Journal of Institute of Medicine, vol. 33, no. 2, pp. 1–17, 2011. View at Google Scholar
  34. V. Gupta, P. Datta, and J. Chander, “Prevalence of metallo-β lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India,” Journal of Infection, vol. 52, no. 5, pp. 311–314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Padiyath, C. Hemachandra, P. S. Rao, and S. Kotigadde, “Detection of extended spectrum β-lactamase, AmpC β-lactamase and metallo β-lactamase in clinical isolates of Pseudomonas aeruginosa,” Journal of Pharmaceutical and Biomedical Science, vol. 33, no. 33, pp. 1506–1515, 2013. View at Google Scholar
  36. M. Chaudhary and A. Payasi, “Rising antimicrobial resistance of Pseudomonas aeruginosa isolated from clinical specimens in India,” Journal of Proteomics and Bioinformatics, vol. 6, no. 1, pp. 5–9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. “Prevalence of plasmid-mediated AmpC β-lactamases in Klebsiella pneumoniae (KP), Klebsiella oxytoca (KO), Proteus mirabilis (PM), and Salmonella (S) isolates from 42 ICU and 21 non-ICU sites in the United States,” in Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICCAC '03), J. A. Black, E. S. Moland, A. Hossain, T. J. Lockhart, L. B. Olson, and K. S. Thamson, Eds., Chicago, Ill, USA, September 2003.
  38. S. Upadhyay, M. R. Sen, and A. Bhattacharjee, “Presence of different beta-lactamase classes among clinical isolates of Pseudomonas aeruginosa expressing AmpC beta-lactamase enzyme,” Journal of Infection in Developing Countries, vol. 4, no. 4, pp. 239–242, 2010. View at Google Scholar · View at Scopus